ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.
ECDC presents lessons learned from the response of Europe’s public health sector to the pandemic and highlights follow up actions addressing relevant issues which could improve Europe’s pandemic preparedness.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing below 10% positivity in week 16/2023.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023 when it reached 21% positivity, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and is coming to an end with positivity falling below the 10% seasonal threshold in week 16/2023 (9%).
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing below 10% positivity in week 16/2023.